Kevin Heal
Stock Analyst at Argus Research
(2.85)
# 1,361
Out of 4,810 analysts
46
Total ratings
51.61%
Success rate
4.84%
Average return
Main Sectors:
Stocks Rated by Kevin Heal
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
NDAQ Nasdaq | Maintains: Buy | $76 → $82 | $73.17 | +12.07% | 4 | Nov 5, 2024 | |
RF Regions Financial | Upgrades: Buy | $26 | $19.43 | +33.81% | 2 | Oct 24, 2024 | |
ZION Zions Bancorporation, National Association | Downgrades: Hold | n/a | $43.79 | - | 2 | Jul 25, 2024 | |
HBAN Huntington Bancshares | Maintains: Buy | $15 → $16 | $13.40 | +19.40% | 3 | Jul 22, 2024 | |
MET MetLife | Maintains: Buy | $77 → $80 | $72.71 | +10.03% | 2 | May 22, 2024 | |
ICE Intercontinental Exchange | Reiterates: Buy | $153 | $159.95 | -4.35% | 5 | May 21, 2024 | |
AMP Ameriprise Financial | Maintains: Buy | $440 → $460 | $476.44 | -3.45% | 1 | May 6, 2024 | |
CFG Citizens Financial Group | Maintains: Buy | $36 → $39 | $36.10 | +8.03% | 5 | Apr 24, 2024 | |
CME CME Group | Maintains: Buy | $225 → $245 | $262.87 | -6.80% | 2 | Mar 6, 2024 | |
RITM Rithm Capital | Maintains: Buy | $11 → $12 | $10.13 | +18.46% | 1 | Mar 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $52.99 | - | 3 | Jan 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $217.84 | - | 5 | Nov 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $12.50 | - | 3 | May 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $17.96 | - | 1 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.41 | - | 1 | Feb 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.59 | - | 2 | Jun 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $194.54 | - | 2 | May 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $185 | $284.80 | -35.04% | 2 | Jul 30, 2021 |
Nasdaq
Nov 5, 2024
Maintains: Buy
Price Target: $76 → $82
Current: $73.17
Upside: +12.07%
Regions Financial
Oct 24, 2024
Upgrades: Buy
Price Target: $26
Current: $19.43
Upside: +33.81%
Zions Bancorporation, National Association
Jul 25, 2024
Downgrades: Hold
Price Target: n/a
Current: $43.79
Upside: -
Huntington Bancshares
Jul 22, 2024
Maintains: Buy
Price Target: $15 → $16
Current: $13.40
Upside: +19.40%
MetLife
May 22, 2024
Maintains: Buy
Price Target: $77 → $80
Current: $72.71
Upside: +10.03%
Intercontinental Exchange
May 21, 2024
Reiterates: Buy
Price Target: $153
Current: $159.95
Upside: -4.35%
Ameriprise Financial
May 6, 2024
Maintains: Buy
Price Target: $440 → $460
Current: $476.44
Upside: -3.45%
Citizens Financial Group
Apr 24, 2024
Maintains: Buy
Price Target: $36 → $39
Current: $36.10
Upside: +8.03%
CME Group
Mar 6, 2024
Maintains: Buy
Price Target: $225 → $245
Current: $262.87
Upside: -6.80%
Rithm Capital
Mar 5, 2024
Maintains: Buy
Price Target: $11 → $12
Current: $10.13
Upside: +18.46%
Jan 29, 2024
Downgrades: Hold
Price Target: n/a
Current: $52.99
Upside: -
Nov 16, 2023
Downgrades: Hold
Price Target: n/a
Current: $217.84
Upside: -
May 22, 2023
Upgrades: Hold
Price Target: n/a
Current: $12.50
Upside: -
Feb 21, 2023
Downgrades: Hold
Price Target: n/a
Current: $17.96
Upside: -
Feb 6, 2023
Downgrades: Hold
Price Target: n/a
Current: $8.41
Upside: -
Jun 2, 2022
Downgrades: Hold
Price Target: n/a
Current: $4.59
Upside: -
May 20, 2022
Downgrades: Hold
Price Target: n/a
Current: $194.54
Upside: -
Jul 30, 2021
Upgrades: Buy
Price Target: $185
Current: $284.80
Upside: -35.04%